Information shared by women with metastatic breast cancer on social media platforms like Twitter may be a timely source of data for policymakers hoping to improve care and outcomes for these patients.
Feb 3, 2021
0
1
(HealthDay)—Could a cancer diagnosis sometimes produce positive life changes? In a new study, many people with colon cancer, even in advanced stages, believed their diagnosis had brought some beneficial effects to their ...
Jan 11, 2021
0
10
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health, have shown that a triple drug combination—of irinotecan, ...
Dec 24, 2020
0
15
Surgery, in addition to treatments like chemotherapy and radiation therapy, may increase the length of survival for metastatic breast cancer patients, according to Penn State College of Medicine and Penn State Cancer Institute ...
Dec 22, 2020
0
2
(HealthDay)—For the first-line treatment of microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal cancer, pembrolizumab is superior to chemotherapy for prolonging progression-free ...
Dec 3, 2020
0
0
University of Virginia Cancer Center researchers have identified a gene responsible for the spread of triple-negative breast cancer to other parts of the body—a process called metastasis—and developed a potential way ...
Nov 20, 2020
0
78
A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.
Nov 20, 2020
0
3
(HealthDay)—For patients with metastatic colorectal cancer who have resectable liver metastases, survival outcomes at five years do not differ significantly for treatment with laparoscopic versus open liver resection, according ...
Nov 17, 2020
0
1
Menarini Silicon Biosystems has announced the publication of a research study providing support for the reliability of using circulating tumor cell (CTC) count to guide frontline therapy choice for patients with estrogen ...
Nov 9, 2020
0
3
University of Cincinnati clinician-scientist Soma Sengupta, MD, Ph.D., says that new findings from her and Daniel Pomeranz Krummel's, Ph.D., team might have identified a treatment-boosting drug to enhance effectiveness of ...
Nov 5, 2020
0
3
